Universal-Beteiligungs- und Servicegesellschaft’s Apogee Therapeutics APGE Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.1M	Sell	121,258 -6,757	-5%	-$609K	0.02%	472
2026 Q1	$10.8M	Buy	128,015 +386	+0.3%	+$28K	0.02%	578
2025 Q4	$9.63M	Sell	127,629 -3,807	-3%	-$240K	0.02%	627
2025 Q3	$5.22M	Buy	131,436 +5,607	+4%	+$214K	0.01%	853
2025 Q2	$5.46M	Sell	125,829 -1,379	-1%	-$52.5K	0.01%	795
2025 Q1	$4.75M	Sell	127,208 -16,744	-12%	-$647K	0.01%	820
2024 Q4	$6.52M	Buy	+143,952	New	+$7.34M	0.01%	649

Other funds holding APGE

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's APGE Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Apogee Therapeutics (APGE) stake by 5.3% in Q2 2026, selling an estimated $609K and leaving 121,258 shares worth $16.1M. The position accounts for 0.02% of the portfolio, ranked #472.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in APGE in Q4 2024 and has held it in 7 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 121,258 shares of Apogee Therapeutics worth $16.1M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 6,757 Apogee Therapeutics shares in Q2 2026, an estimated $609K.
Apogee Therapeutics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #472 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Apogee Therapeutics in Q4 2024 and has held it in 7 quarters since.
289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.